证券代码：603716 证券简称：塞力医疗 公告编号：2025-041 债券代码：113601 债券简称：塞力转债 塞力斯医疗科技集团股份有限公司 关于控股子、孙公司开立募集资金专用账户并签署 募集资金专户存储四方监管协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、募集资金基本情况 经中国证券监督管理委员会核发的《关于核准塞力斯医疗科技股份有限公司 公开发行可转换公司债券的批复》（证监许可20201033 号）核准，塞力斯医 疗科技集团股份有限公司（原名称为塞力斯医疗科技股份有限公司，以下简称"公 司"）于 2020 年 8 月 21 日公开发行面值总额 54,331 万元可转换公司债券，募 集资金总额为人民币 543,310,000.00 元，扣除承销保荐费用及与本次可转换公 司债券发行直接相关的其他发行费用（不含增值税）后的募集资金净额为人民币 会计师事务所（特殊普通合伙）于 2020 年 8 月 27 日出具的众环验字（2020）010054 号验资报告审验，扣除承销保荐费用及与本次可转换公司债券发行直接 ...

Core Insights - OpenAI has launched HealthBench, an open-source benchmark for evaluating the performance and safety of large language models in the healthcare sector, which has sparked widespread discussion in the industry [1][3] - The benchmark was developed with the participation of 262 practicing doctors from 60 countries and integrates 5,000 real medical dialogue data, utilizing 48,562 unique scoring criteria created by doctors for meaningful open assessments [1][3] - The introduction of HealthBench is expected to enhance the scientific and comprehensive evaluation of AI medical models, accelerating the application of AI technology in healthcare and providing new development opportunities for related companies [1][3] Group 1: HealthBench Overview - HealthBench consists of 7 themes and 5 evaluation dimensions, focusing on areas such as emergency referrals and professional communication, with dimensions including accuracy and contextual understanding [3][4] - OpenAI has also introduced two special versions of HealthBench: HealthBench Consensus, which includes 34 critical evaluation dimensions verified by doctors, and HealthBench Hard, which presents more challenging assessment scenarios [4] - The credibility of HealthBench has been supported by a meta-evaluation comparing model scores with human doctor scores, showing high consistency in 6 out of 7 evaluation areas [4] Group 2: Trends in AI Healthcare Applications - The AI healthcare market is projected to grow at an annual rate of 43% from 2024 to 2032, potentially reaching a market size of $491 billion [6] - AI is expected to enhance healthcare accessibility and efficiency, addressing issues like personnel shortages in hospitals and improving diagnostic accuracy [6] - The evolution of AI in healthcare has transitioned from rule-driven to data-driven approaches, now entering a multi-modal integration phase, allowing for better understanding and modeling of diverse medical data [6][7] Group 3: Future Directions in AI Models - The focus of competition among large models has shifted from merely increasing parameter size to optimizing model efficiency and performance under limited computational resources [7] - Key trends in AI applications within the pharmaceutical industry include the emergence of models as products, local and edge deployment, and rapid expansion of AI applications in research and development [7][8] - The pharmaceutical industry is expected to see a rise in specialized models tailored for specific scenarios, enhancing the adaptability and effectiveness of AI solutions [7][8]

Group 1 - The 35th National Day for Assisting the Disabled is on May 18, 2025, with the 7th National Self-Reliance Model and Advanced Work for Assisting the Disabled Commendation Conference held in Beijing on May 16 [1] - Wuhan University of Science and Technology teacher Yuan Xin and Hubei Radio and Television Station music broadcast chief editor Li Jun were awarded the title of "National Self-Reliance Model" [1] - The Wuhan City Haoran Disabled Persons Public Service Center was recognized as a "National Advanced Collective for Disabled Persons Work" [1] Group 2 - Yuan Xin, who lost his right arm in a car accident at the age of 3, has received over 70 awards and honors during his 9 years at Wuhan University of Science and Technology, including national and provincial recognitions [1][2] - Li Jun, who became disabled due to illness, has hosted multiple award-winning programs and initiated the "Little Bee" barrier-free movie viewing service team, helping over 500 disabled individuals with employment and entrepreneurship [2] - The Wuhan City Haoran Disabled Persons Public Service Center, founded in 2017, has assisted over 300 individuals with spinal cord injuries and provided voluntary services to over 50,000 people [2] Group 3 - Chen Xiangdong, director of the anesthesiology department at Huazhong University of Science and Technology, has dedicated over 30 years to medical technology for assisting the disabled, developing sleep monitoring devices and limb assistive devices [2] - Chen's team has organized free medical consultations in remote areas, treating severe scoliosis patients and providing assistance to hospitalized disabled patients [2]

经营质效见韧性 资本市场是促进民营经济发展壮大的重要平台。目前，科创板民营企业占比超八成，市值超3.8万亿 元。 科创板民企首发募集资金超过5300亿元，资金大部分投向研发及产业化项目，加速了各领域的产业升级 与经济发展。 科创板民营企业经营质效、发展活力、投资信心实现稳步提升。2024年度，科创板民营企业合计实现营 收9091.97亿元，实现净利润225.99亿元。其中，195家科创板民营企业的营业收入、净利润双增长，41 家公司营业收入增速超50%，86家公司净利润增速超50%。 结合2024年业绩表现看，158家公司营业收入超10亿元，145家公司净利润超1亿元。部分企业实现跨越 式发展，154家公司上市后营收实现翻番，70家公司净利润实现翻倍或扭亏为盈，形成"创新—资本—产 业"的良性循环。 民营企业的回款效率是实现长期健康发展的重要基础。2024年度，科创板民营企业整体回款情况得到改 善，销售商品、提供劳务收到的现金金额合计1.05万亿元，同比增加3.7%，较收入增速高出2个百分 点。回款效率的提升进一步提高了科创板民营企业研发资金可获得性，为持续创新提供了现金流保障。 研发创新显活力 创新是科创板 ...

Financial Performance - In 2024, the company achieved operating revenue of 1,606.32 million yuan, a year-on-year increase of 1.45% [2] - The net profit attributable to the parent company was 349.68 million yuan, a decrease of 29.07% compared to the previous year [2] - Earnings per share were 0.73 yuan, down 30.48% year-on-year, primarily due to a decline in gross profit from high polymer products [3] - In Q1 2025, operating revenue was 324.86 million yuan, a decrease of 17.69% year-on-year [3] - The net profit attributable to the parent company for Q1 2025 was 80.42 million yuan, down 33.75% year-on-year, with earnings per share at 0.17 yuan, a decrease of 32.00% [3] Product Applications - PVP is used in the new energy sector as a dispersant for carbon nanotubes and in solid-state batteries for material dispersion and interface optimization [3] - In 2024, the expected shipment volume for new energy applications is over 3,000 tons, with a projected increase in 2025 [3] - PVP's application in electronic skin focuses on material modification and conductive network construction, with no large-scale shipments currently [4] Pricing and Market Impact - PVP prices have significantly decreased compared to the previous two years and are currently stabilizing [4] - The company anticipates an increase in average product prices as the proportion of high-end products rises [4] - Approximately 50% of PVP exports are to Europe, the Middle East, Southeast Asia, and India, with exports to the U.S. accounting for only 3%-5% [5] Product Overview - Euriz is a copolymer of vinyl ether/maleic anhydride, known for its linear molecular structure and good chemical stability [5] - In 2024, Euriz sales are expected to reach about 1,500 tons, with approximately 90% for export and a high unit price [5] - The estimated shipment volume for Euriz in 2025 is over 2,000 tons, with a gross profit margin of 60-70% [5]

Group 1 - The core viewpoint of the article highlights the rapid integration of large language models into the healthcare system, with 98 out of the top 100 hospitals in China claiming to have completed model deployment by April 30, 2025 [1] - Among these hospitals, 38 have developed 55 vertical medical models tailored to their specific needs based on general models [1][4] - The shift from "buyers" to "developers" indicates that doctors are becoming crucial contributors to AI development in healthcare [2][12] Group 2 - The emergence of specialized models marks a new era in healthcare AI, with hospitals increasingly focusing on vertical models that address specific diseases and clinical needs [4][6] - The DeepSeek model has significantly lowered the barriers for hospitals to deploy large models, allowing even those with no prior experience to customize and implement them [4][11] - As of April 30, 2025, there are 22 specialized vertical models in development, covering various medical fields such as cardiology, nephrology, and oncology [7][9] Group 3 - The collaboration between hospitals and enterprises remains the dominant model for developing vertical medical models, although independent hospital development is on the rise [13][15] - Major companies like Huawei, China Telecom, and iFlytek are actively involved in the development of these vertical models, indicating a trend towards increased collaboration between hospitals and tech firms [16][19] - The regulatory landscape for large models is evolving, with potential classification as medical devices requiring rigorous approval processes [19][20]

| 投资者关系活 | 特定对象调研 □分析师会议 | | --- | --- | | 动类别 | 业绩说明会 媒体采访  | | | □新闻发布会 □路演活动 | | | □现场参观 | | | □其他 | | 参与单位名称 及人员姓名 | 参与公司 2024 年度网上业绩说明会的投资者 | | 时间 | 2024 年 5 月 14 日（星期三）15:00-16:30 | | 地点 | 价值在线（www.ir-online.cn） | | 上市公司参与 | 董事、总经理 魏乃绪先生 | | 人员姓名 | 副总经理、董事会秘书 王万元先生 | | | 财务总监 钱本成先生 | | | 独立董事 叶肖剑先生 | | | 公司 2024 年度业绩说明会采用网络文字互动的方式举行，本次业绩说明会主 | | | 要问题及答复内容整理如下： | | | 1. 路楠与苍南建投的股份转让协议办理完毕了吗？公司实际控制人变成苍南县 | | | 财政局了吗？ | | | 回复：尊敬的投资者，您好！苍南县工业建设投资有限公司与公司第一大股东路楠 | | 投资者关系活 | 于 2025 年 4 月 26 日签署了《股份转让协议 ...

Group 1 - The event "AI + New Traditional Chinese Medicine Technology Free Health Training and Chronic Disease Risk Screening" aims to enhance community residents' health awareness and self-care abilities [1] - The initiative is a collaboration between Dongguan Community and Zhongjing Second Community Health Service Center, focusing on early detection and intervention of severe health risks such as myocardial infarction and cerebral infarction [1][5] - Since the launch on April 19, a total of 389 residents have participated in the screening, with health risk reports sent to participants' mobile phones in real-time [5] Group 2 - Medical experts conducted engaging health knowledge lectures covering disease prevention, dietary recommendations, and exercise methods, emphasizing the importance of lifestyle habits [3] - The community offers various screening projects, including non-invasive AI retinal imaging for detecting risks of heart and brain diseases, diabetes, and dementia, as well as specialized checks for high-risk groups [3] - The community leader stated the commitment to continue such activities to enhance chronic disease prevention awareness and contribute to building a healthy community [5]

证券代码：603205 证券简称：健尔康 公告编号：2025-015 健尔康医疗科技股份有限公司 2024年年度股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 本次会议是否有否决议案：无 一、会议召开和出席情况 (一)股东大会召开的时间：2025年5月13日 (二)股东大会召开的地点：江苏省常州市金坛区直溪镇工业集中区健尔康路1号办公楼一楼会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： ■ 二、议案审议情况 (四)表决方式是否符合《公司法》及《公司章程》的规定，股东大会主持情况等。 会议召集、召开、议案审议程序等方面符合有关法律、行政法规、部门规章、规范性文件和《公司章 程》的规定。 (五)公司董事和董事会秘书的出席情况 1、公司在任董事9人，出席9人； 2、公司在任监事3人，列席3人； 3、公司董事会秘书列席会议； 4、公司高级管理人员列席会议。 (一)非累积投票议案 1、议案名称：《关于公司〈2024年度董事会工作报告〉的议案》 审议结果：通过 ■ 2、议 ...